CN101104069A - Traditional Chinese medicine formula for treating liver (biliary) inflammation - Google Patents
Traditional Chinese medicine formula for treating liver (biliary) inflammation Download PDFInfo
- Publication number
- CN101104069A CN101104069A CNA2007100150263A CN200710015026A CN101104069A CN 101104069 A CN101104069 A CN 101104069A CN A2007100150263 A CNA2007100150263 A CN A2007100150263A CN 200710015026 A CN200710015026 A CN 200710015026A CN 101104069 A CN101104069 A CN 101104069A
- Authority
- CN
- China
- Prior art keywords
- radix
- liver
- inflammation
- gallbladder
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004185 liver Anatomy 0.000 title claims abstract description 16
- 206010061218 Inflammation Diseases 0.000 title claims abstract description 10
- 230000004054 inflammatory process Effects 0.000 title claims abstract description 10
- 239000003814 drug Substances 0.000 title abstract description 9
- 210000000232 gallbladder Anatomy 0.000 claims abstract description 11
- 210000003038 endothelium Anatomy 0.000 claims abstract description 5
- 239000002994 raw material Substances 0.000 claims description 10
- 241000222336 Ganoderma Species 0.000 claims description 6
- 239000010135 fructus aurantii immaturus Substances 0.000 claims description 5
- 241000208340 Araliaceae Species 0.000 claims description 4
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 4
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 4
- 235000008434 ginseng Nutrition 0.000 claims description 4
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 4
- 241000903946 Clematidis Species 0.000 claims description 3
- 241000628997 Flos Species 0.000 claims description 3
- 239000009636 Huang Qi Substances 0.000 claims description 3
- 210000000582 semen Anatomy 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims 1
- 239000008280 blood Substances 0.000 abstract description 12
- 210000004369 blood Anatomy 0.000 abstract description 12
- 230000000694 effects Effects 0.000 abstract description 8
- 206010008909 Chronic Hepatitis Diseases 0.000 abstract description 5
- 201000001352 cholecystitis Diseases 0.000 abstract description 5
- 201000001883 cholelithiasis Diseases 0.000 abstract description 5
- 208000006454 hepatitis Diseases 0.000 abstract description 5
- 206010008617 Cholecystitis chronic Diseases 0.000 abstract description 3
- 231100000915 pathological change Toxicity 0.000 abstract description 3
- 230000036285 pathological change Effects 0.000 abstract description 3
- 238000000034 method Methods 0.000 abstract description 2
- PZHWYURJZAPXAN-ILOFNVQHSA-N (+)-absinthin Chemical compound C([C@H]1[C@H](C)C(=O)O[C@@H]11)C[C@](C)(O)[C@@H]2[C@H]3[C@@H]4[C@H]5[C@@](C)(O)CC[C@H]6[C@H](C)C(=O)O[C@@H]6C5=C(C)[C@@H]4[C@]21C(C)=C3 PZHWYURJZAPXAN-ILOFNVQHSA-N 0.000 abstract 1
- GHODAOZUPBDHHO-UHFFFAOYSA-N 10',11'-epiabsinthin Natural products CC1CC2C3C4C(=C(C)C3C15C6OC(=O)C(C)C6CCC(C)(O)C25)C7OC(=O)C(C)C7CCC4(C)O GHODAOZUPBDHHO-UHFFFAOYSA-N 0.000 abstract 1
- PZHWYURJZAPXAN-UHFFFAOYSA-N Absynthin Natural products C12OC(=O)C(C)C2CCC(C)(O)C2C3C4C5C(C)(O)CCC6C(C)C(=O)OC6C5=C(C)C4C21C(C)=C3 PZHWYURJZAPXAN-UHFFFAOYSA-N 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241000202726 Bupleurum Species 0.000 abstract 1
- 244000150195 Cyperus longus Species 0.000 abstract 1
- 235000018109 Cyperus longus Nutrition 0.000 abstract 1
- 244000075634 Cyperus rotundus Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 244000010000 Hovenia dulcis Species 0.000 abstract 1
- 235000008584 Hovenia dulcis Nutrition 0.000 abstract 1
- 244000236658 Paeonia lactiflora Species 0.000 abstract 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 abstract 1
- 244000179560 Prunella vulgaris Species 0.000 abstract 1
- 244000153955 Reynoutria sachalinensis Species 0.000 abstract 1
- 235000003202 Reynoutria sachalinensis Nutrition 0.000 abstract 1
- 235000005010 Scirpus paludosus Nutrition 0.000 abstract 1
- GMKDAIKQCOMFGO-UHFFFAOYSA-N absinthin Natural products CC1C2CCC(C)(O)C34C5CC(C)(C3C=C(C)C4C2OC1=O)C6=C5C(C)(O)CCC7C(C)C(=O)OC67 GMKDAIKQCOMFGO-UHFFFAOYSA-N 0.000 abstract 1
- 235000003373 curcuma longa Nutrition 0.000 abstract 1
- 239000001215 curcuma longa l. root Substances 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 229940107131 ginseng root Drugs 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 description 6
- 208000019425 cirrhosis of liver Diseases 0.000 description 4
- 206010000077 Abdominal mass Diseases 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 206010023126 Jaundice Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 206010019668 Hepatic fibrosis Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000002279 cholagogic effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 208000020694 gallbladder disease Diseases 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a herbal prescription for treating the liver (gallbladder) inflammation in the traditional Chinese medicine preparation field. The technique proposal is that: the invention includes materials with parts by following weights: eight to twelve parts of bupleurum, twelve to fifteen parts of each of white peony root (stir-fried), hovenia dulcis, immature orange fruit, endothelium corneum gigeriae, nutgrass galingale rhizome, turmeric root tuber, ginseng root, prunella, Chinese angelica and absinthin, ten to twelve parts of giant knotweed rhizome, and three to five parts of liquorice. The invention has effects of relieving liver Qi stagnation and stagnation eliminating and blood stasis removing. The effective rate and the cure rate of the invention for treating the chronic hepatitis, hepatocirrhosis, chronic cholecystitis, cholelithiasis and pathological changes such as pain in chest and hypochondrium caused by liver Qi stagnation and Qi stagnation and blood stasis are respectively ninety two percent and eighty seven percent.
Description
Technical field
The present invention relates to the Chinese medicinal formulae of a kind of treatment liver (gallbladder) inflammation of field of traditional Chinese.
Background technology
At present the drug main of treatment chronic hepatitis, liver cirrhosis, chronic cholecystitis, cholelithiasis and the pathological changes such as pain in chest and hypochondrium that cause because of depression of liver-QI, qi depression to blood stasis will be based on Western medicine antibiotic medicine class, and the western medicine side effect is bigger, and easily recurrence; The treatment by Chinese herbs kind is few, and treatment cycle is long, and curative effect is low and slow.
Summary of the invention
Purpose of the present invention is exactly the defective that exists at prior art, and the Chinese medicinal formulae of little treatment liver (gallbladder) inflammation of a kind of good effect, side effect is provided.The raw material that comprises following weight portion is formed: Radix Bupleuri 8-12, each 12-15 of Radix Paeoniae Alba (parched), Fructus Aurantii, Fructus Aurantii Immaturus, Endothelium Corneum Gigeriae Galli, Rhizoma Cyperi, Radix Curcumae, Radix Ginseng, Spica Prunellae, Radix Angelicae Sinensis and Herba Artemisiae Scopariae, Rhizoma Polygoni Cuspidati 10-12, Radix Glycyrrhizae 3-5.
At chronic hepatitis patient, comprise also in the such scheme that the raw material of following weight portion is formed: each 10-12 of Herba Patriniae, Herba Sedi, Fructus Schisandrae Chinensis, Ganoderma and Fructus Lycii.
At liver cirrhosis patient, comprise also in the such scheme that the raw material of following weight portion is formed: each 10-12 of Ganoderma, Herba Patriniae, Fructus Lycii, Rhizoma Atractylodis Macrocephalae (parched), Radix Astragali, water tinctorius seed and Stigma Maydis.
At the cholecystitis patient, comprise also in the such scheme that the raw material of following weight portion is formed: each 10-12 of Herba Taraxaci, Herba Patriniae, Radix Scutellariae, FLOS MUME and Pericarpium Citri Reticulatae Viride.
At the cholelithiasis patient, comprise also in the such scheme that the raw material of following weight portion is formed: each 8-10 of Herba Lysimachiae, Semen Arecae, the Radix Aucklandiae, Radix Et Rhizoma Rhei, Semen Vaccariae and Radix Clematidis.
The present invention has dispersing the stagnated live-QI to relieve the stagnation of QI, the effect of stagnant removing blood stasis disappears.The Radix Bupleuri bar reaches irritability and stagnation resolving in the side, dredges sharp liver and gall and removes stagnant heat.Radix Paeoniae Alba nourishing blood to suppress the hyperactive liver and battalion's yin fluid astringing, relieving spasm to stop pain is also used then coordination of potent and mild therapies with Radix Bupleuri, is association of activity and inertia.The slow power of Fructus Aurantii property is little, and circulation of qi promoting is coerced diaphragm soon in breast but relieving distension is full; The impatient power of Fructus Aurantii Immaturus is strong, the circulation of qi promoting the turbid descending, and the painful abdominal mass that disappears is loose long-pending; Fructus Aurantii, Fructus Aurantii Immaturus and usefulness, the circulation of qi promoting painful abdominal mass that disappears, its benefit is clear.Rhizoma Cyperi is a disorder of QI Directorate-General DG, activating QI to alleviate the depression, and stagnant dissipating blood stasis disappears.Endothelium Corneum Gigeriae Galli is the activating the spleen master product that help digestion, and can remove expand lead long-pending, the dissipating blood stasis fossil; Two medicines, 5 usefulness are to qi and blood stagnation, and distension painful abdominal mass calculus curative effect is very good.The Radix Curcumae promoting the function of the gallbladder to alleviate jaundice, the removing blood stasis pain relieving, the stasis of blood of controlling breast abdomen side of body rib partially stagnates.Radix Ginseng, Spica Prunellae, the Radix Angelicae Sinensis blood circulation promoting competent silt, clearing heat and relieving fidgetness, the blood vessels of kind logical whole body, its energy anti-hepatic fibrosis promotes liver cell regeneration.Herba Artemisiae Scopariae is slightly cold, hepatic cholagogic, and removing damp-heat, the jaundice eliminating detoxifcation is treatment liver-gallbladder disease key medicine.Rhizoma Polygoni Cuspidati is gone into the liver and gall warp, and removing blood stasis is invigorated blood circulation, the function of gallbladder promoting detoxifcation.The Radix Glycyrrhizae liver detoxification, relieving spasm to stop pain, peace and the five internal organs are coordinated all medicines.The effective percentage 92% of the pathological changes such as pain in chest and hypochondrium that cause to chronic hepatitis, liver cirrhosis, chronic cholecystitis, cholelithiasis and because of depression of liver-QI, qi depression to blood stasis, cure rate 87%.
The specific embodiment
Enumerate embodiment below and be further described (each embodiment disposes with daily dosage):
Embodiment 1: Radix Bupleuri 8g, Radix Paeoniae Alba (parched) 12g, Fructus Aurantii 12g, Fructus Aurantii Immaturus 12g, Endothelium Corneum Gigeriae Galli 12g, Rhizoma Cyperi 12g, Radix Curcumae 12g, Radix Ginseng, Spica Prunellae, Radix Angelicae Sinensis 12g, Herba Artemisiae Scopariae 12g, Rhizoma Polygoni Cuspidati 10g, Radix Glycyrrhizae 3g.
Embodiment 2: at chronic hepatitis patient, on the basis of embodiment 1, increase Herba Patriniae, Herba Sedi, Fructus Schisandrae Chinensis, Ganoderma and each 10g of Fructus Lycii.
Embodiment 3: at liver cirrhosis patient, on the basis of embodiment 1, increase Ganoderma, Herba Patriniae, Fructus Lycii, Rhizoma Atractylodis Macrocephalae (parched), Radix Astragali, water tinctorius seed and each 10g of Stigma Maydis.
Embodiment 4: at the cholecystitis patient, on the basis of embodiment 1, increase Herba Taraxaci, Herba Patriniae, Radix Scutellariae, FLOS MUME and each 10g of Pericarpium Citri Reticulatae Viride.
Embodiment 5: at the cholelithiasis patient, on the basis of embodiment 1, increase Herba Lysimachiae, Semen Arecae, the Radix Aucklandiae, Radix Et Rhizoma Rhei, Semen Vaccariae and each 8g of Radix Clematidis.
Adopt prescription of the present invention can utilize existing manufacturing technique to prepare oral liquid or tablet, capsule etc., 1 dose of day clothes are respectively obeyed 1 time sooner or later.Usually it was a course of treatment with 10-15 days.
Claims (5)
1. the Chinese medicinal formulae of treatment liver (gallbladder) inflammation, it is characterized in that comprising the raw material composition of following weight portion: Radix Bupleuri 8-12, each 12-15 of Radix Paeoniae Alba (parched), Fructus Aurantii, Fructus Aurantii Immaturus, Endothelium Corneum Gigeriae Galli, Rhizoma Cyperi, Radix Curcumae, Radix Ginseng, Spica Prunellae, Radix Angelicae Sinensis and Herba Artemisiae Scopariae, Rhizoma Polygoni Cuspidati 10-12, Radix Glycyrrhizae 3-5.
2. the Chinese medicinal formulae of treatment according to claim 1 liver (gallbladder) inflammation is characterized in that the raw material that also comprises following weight portion forms: each 10-12 of Herba Patriniae, Herba Sedi, Fructus Schisandrae Chinensis, Ganoderma and Fructus Lycii.
3. the Chinese medicinal formulae of treatment according to claim 1 liver (gallbladder) inflammation is characterized in that the raw material that also comprises following weight portion forms: each 10-12 of Ganoderma, Herba Patriniae, Fructus Lycii, Rhizoma Atractylodis Macrocephalae (parched), Radix Astragali, water tinctorius seed and Stigma Maydis.
4. the Chinese medicinal formulae of treatment according to claim 1 liver (gallbladder) inflammation is characterized in that the raw material that also comprises following weight portion forms: each 10-12 of Herba Taraxaci, Herba Patriniae, Radix Scutellariae, FLOS MUME and Pericarpium Citri Reticulatae Viride.
5. the Chinese medicinal formulae of treatment according to claim 1 liver (gallbladder) inflammation is characterized in that the raw material that also comprises following weight portion forms: each 8-10 of Herba Lysimachiae, Semen Arecae, the Radix Aucklandiae, Radix Et Rhizoma Rhei, Semen Vaccariae and Radix Clematidis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2007100150263A CN101104069A (en) | 2007-06-14 | 2007-06-14 | Traditional Chinese medicine formula for treating liver (biliary) inflammation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2007100150263A CN101104069A (en) | 2007-06-14 | 2007-06-14 | Traditional Chinese medicine formula for treating liver (biliary) inflammation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101104069A true CN101104069A (en) | 2008-01-16 |
Family
ID=38998276
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2007100150263A Pending CN101104069A (en) | 2007-06-14 | 2007-06-14 | Traditional Chinese medicine formula for treating liver (biliary) inflammation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101104069A (en) |
Cited By (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102727837A (en) * | 2012-07-23 | 2012-10-17 | 鲁道宗 | Traditional Chinese medicine prescription for treating cholelithiasis and chronic cholecystitis |
| CN102872362A (en) * | 2012-10-13 | 2013-01-16 | 郭伟华 | Traditional Chinese medicine for treating chronic cholecystitis |
| CN102973673A (en) * | 2012-12-06 | 2013-03-20 | 常熟富士莱医药化工有限公司 | Pharmaceutical preparation for treating hepatopyretic disease |
| CN103393963A (en) * | 2013-07-20 | 2013-11-20 | 邵梅 | Traditional Chinese medicine composition for treating chronic cholecystitis |
| CN103393979A (en) * | 2013-08-19 | 2013-11-20 | 张成娟 | Drug for curing cholecystitis |
| CN103599370A (en) * | 2013-11-14 | 2014-02-26 | 许丽娜 | Traditional Chinese medicine preparation for treating blood stasis type acute cholecystitis |
| CN105169278A (en) * | 2015-10-12 | 2015-12-23 | 青岛恒波仪器有限公司 | Dandelion oral liquid capable of protecting liver and benefiting gallbladder and preparation method thereof |
| CN105169275A (en) * | 2015-10-12 | 2015-12-23 | 青岛恒波仪器有限公司 | Rheum officinale oral liquid capable of protecting liver and benefiting gallbladder and preparation method thereof |
| CN105168760A (en) * | 2015-08-14 | 2015-12-23 | 高伟 | Traditional Chinese medicine treating liver qi stagnation chronic cholecystitis and preparation method therefor |
| CN105168878A (en) * | 2015-09-18 | 2015-12-23 | 马鞍山德宏堂生物科技有限公司 | Traditional Chinese medicine decoction for treating costalgia due to Qi stagnation and blood stasis |
| CN105193957A (en) * | 2015-10-30 | 2015-12-30 | 丁明辉 | Traditional Chinese medicine composition for treating liver cirrhosis |
| CN107551182A (en) * | 2017-10-27 | 2018-01-09 | 王彦春 | A kind of Chinese traditional compound medicine for being used to treat hepatic disorder |
| CN109498776A (en) * | 2017-09-14 | 2019-03-22 | 周春云 | Liver and gallbladder pancreas spleen ball |
| CN110179951A (en) * | 2019-06-28 | 2019-08-30 | 宗吉红 | A kind of Chinese medicine composition and preparation method thereof for recuperating under medical treatment virus hepatitis |
-
2007
- 2007-06-14 CN CNA2007100150263A patent/CN101104069A/en active Pending
Cited By (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102727837A (en) * | 2012-07-23 | 2012-10-17 | 鲁道宗 | Traditional Chinese medicine prescription for treating cholelithiasis and chronic cholecystitis |
| CN102872362A (en) * | 2012-10-13 | 2013-01-16 | 郭伟华 | Traditional Chinese medicine for treating chronic cholecystitis |
| CN102872362B (en) * | 2012-10-13 | 2014-01-22 | 初艳红 | Traditional Chinese medicine for treating chronic cholecystitis |
| CN102973673A (en) * | 2012-12-06 | 2013-03-20 | 常熟富士莱医药化工有限公司 | Pharmaceutical preparation for treating hepatopyretic disease |
| CN103393963A (en) * | 2013-07-20 | 2013-11-20 | 邵梅 | Traditional Chinese medicine composition for treating chronic cholecystitis |
| CN103393979A (en) * | 2013-08-19 | 2013-11-20 | 张成娟 | Drug for curing cholecystitis |
| CN103393979B (en) * | 2013-08-19 | 2015-02-25 | 张成娟 | Drug for curing cholecystitis |
| CN103599370A (en) * | 2013-11-14 | 2014-02-26 | 许丽娜 | Traditional Chinese medicine preparation for treating blood stasis type acute cholecystitis |
| CN105168760A (en) * | 2015-08-14 | 2015-12-23 | 高伟 | Traditional Chinese medicine treating liver qi stagnation chronic cholecystitis and preparation method therefor |
| CN105168878A (en) * | 2015-09-18 | 2015-12-23 | 马鞍山德宏堂生物科技有限公司 | Traditional Chinese medicine decoction for treating costalgia due to Qi stagnation and blood stasis |
| CN105169278A (en) * | 2015-10-12 | 2015-12-23 | 青岛恒波仪器有限公司 | Dandelion oral liquid capable of protecting liver and benefiting gallbladder and preparation method thereof |
| CN105169275A (en) * | 2015-10-12 | 2015-12-23 | 青岛恒波仪器有限公司 | Rheum officinale oral liquid capable of protecting liver and benefiting gallbladder and preparation method thereof |
| CN105193957A (en) * | 2015-10-30 | 2015-12-30 | 丁明辉 | Traditional Chinese medicine composition for treating liver cirrhosis |
| CN109498776A (en) * | 2017-09-14 | 2019-03-22 | 周春云 | Liver and gallbladder pancreas spleen ball |
| CN107551182A (en) * | 2017-10-27 | 2018-01-09 | 王彦春 | A kind of Chinese traditional compound medicine for being used to treat hepatic disorder |
| CN110179951A (en) * | 2019-06-28 | 2019-08-30 | 宗吉红 | A kind of Chinese medicine composition and preparation method thereof for recuperating under medical treatment virus hepatitis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101104069A (en) | Traditional Chinese medicine formula for treating liver (biliary) inflammation | |
| CN102178850B (en) | Medicament for treating headache | |
| CN102319407B (en) | Traditional Chinese medicine for treating gastroptosis and extraction method thereof | |
| CN1286518C (en) | Chinese medicinal prescription for treating gastropathy | |
| CN1421234A (en) | Oral liquid for treating hepatitis B | |
| CN102614442B (en) | Traditional Chinese drug capsules with effects of immunity enhancing, blood reinforcing and antiemesis | |
| CN1103223C (en) | Chinese medicine for treating cholecystitis | |
| CN105031307A (en) | Chinese drugs preparation for curing headache and preparation method for Chinese drugs pharmaceutics | |
| CN101518640A (en) | Chinese traditional medicine prescription for treating tumor | |
| CN103041203A (en) | Traditional Chinese medicine formula for treating chronic pyelonephritis | |
| CN102988616B (en) | Chinese medicinal composition for treating anemia | |
| CN104984248A (en) | Traditional Chinese medicinal compound for treating hepatitis | |
| CN101167932A (en) | Traditional Chinese medicine for treating chronic hepatitis B | |
| CN101284113A (en) | Yin toxin Qingyuan pellet | |
| CN101757206A (en) | Chinese medicine preparation for treating chronic colitis | |
| CN103623385B (en) | A kind of Chinese medicine for the treatment of oral ulcer | |
| CN101152540A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
| CN101085137A (en) | Traditional Chinese medicine formula for treating rheumatoid oarthritis | |
| CN103550679A (en) | Traditional Chinese medicine formula for treatment of lithangiuria | |
| CN101468169A (en) | Medicaments assembly for treating menorrhalgia and preparation thereof | |
| CN102240383B (en) | Traditional Chinese medicine composition for treating dysmenorrhea | |
| CN101658636A (en) | Chinese medical composition for treating coronary heart disease | |
| CN101152394A (en) | Traditional Chinese medicine for treating chronic active hepatitis | |
| CN102309600A (en) | Traditional Chinese medicine prescription for treating acne rosacea | |
| CN101032573B (en) | Medicine for treating psoriasis and its preparing process |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20080116 |